Healthcare resource utilization and costs among treatment-naïve people with HIV in state Medicaids: analysis of multi-tablet vs. single-tablet antiretroviral regimen initiators wit... von Chen, M, Christoph, M J, Park, S, Turkistani, F, Weinberg, A R, Trom, C, Zachry, W, Gruber, J, Mordi, U, Rajagopalan, K

Volltext

PRICE ANALYSIS OF THERAPEUTIC BIOLOGICS APPROVED BY THE US FOOD AND DRUG ADMINISTRATION (1986–OCTOBER 2015) von Turkistani, F, Alotaibi, A, Alnafesah, A, Seoane-Vazquez, E

Volltext

ND3 ORPHAN DRUG MARKET ACCESS CHALLENGES IN EUROPEAN UNION FIVE von Bin Sawad, A., Turkistani, F.

Volltext

PNS51 HEALTHCARE RESOURCE INDICATORS: THE WORLDWIDE TOP 3 COUNTRIES WITH THE MOST PHYSICIANS PER CAPITA VS. SAUDI ARABIA von Turkistani, F., Bin Sawad, A.

Volltext

PND67 COMPARISON OF MULTIPLE SCLEROSIS DRUG PRICES IN SAUDI ARABIA VS. UNITED ARAB OF EMIRATES von Turkistani, F., Bin Sawad, A.

Volltext

RWD121 Baseline Characteristics of Patients Prior to Oriahnn Prescription von Turkistani, F, Johns, B, Pinsky, B

Volltext

RWD48 Economic Burden Associated With Sobriety Restrictions to Direct-Acting Antiviral Access Among Medicaid Patients With Hepatitis C Virus: A Retrospective Analysis of Claims fro... von Martin, MT, Rajagopalan, K, Makhija, D, Turkistani, F, Burk, C, Rock, M, Reau, N

Volltext

RWD145 Healthcare Resource Utilization (HCRU) and Costs Among Previously-Treated Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Retrospective Analysis of SEER-Medi... von Rai, P, Paratane, D, Turkistani, F, Min, J, Rajagopalan, K, Hu, X

Volltext

RWD188 Healthcare Cost and Healthcare Resource Utilization (HCRU) Among First-Line (1L) Treated Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC): Analysis of Seer-Medic... von Rai, P, Turkistani, F, Momo, H, Min, J, Syed, SS, Paratane, D, Rajagopalan, K, Aggarwal, H

Volltext

CO192 A Retrospective Database Analysis of US Medicaid Treatment-Naive People With HIV (PWH) With or Without Mental Health Disorders (MHDs) Initiating Single-Tablet Regimens (STRs)... von Chen, M., Turkistani, F., Weinberg, AR, Christoph, MJ, Gruber, J., Trom, C., Park, S., Rajagopalan, K.

Volltext

Continental Comparison of Innovative Drugs Prices, The Case of Oncology Used for Treatment of Solid Tumors in Germany and The United States von Aissaoui, N, Bin Sawad, A, Turkistani, F

Volltext

PCN276 - Continental Comparison of Innovative Drugs Prices, The Case of Oncology Used for Treatment of Solid Tumors in Germany and The United States von Aissaoui, N, Bin Sawad, A, Turkistani, F

Volltext

FINANCIAL INFLUENCE OF CURRENT AND ALTERNATIVE PRICING BENCHMARKS FOR PHARMACY DISPENSED MEDICATIONS IN CALIFORNIA WORKERS’ COMPENSATION SYSTEM von Wilson, L, Turkistani, F, Huang, W, Tran, DM

Volltext

Pivotal Studies of Oncology Drugs Approved in Europe, Which Evidence Based-Medicine? von Aissaoui, A, Turkistani, F, Bin Sawad, A, Aissaoui, N

Volltext

PCN48 - Pivotal Studies of Oncology Drugs Approved in Europe, Which Evidence Based-Medicine? von Aissaoui, A, Turkistani, F, Bin Sawad, A, Aissaoui, N

Volltext

Overall Survival Versus Progression-Free Survival in Oncology Clinical Trials von Aissaoui, A, Bin Sawad, A, Turkistani, F, Aissaoui, N

Volltext

PCN52 - Overall Survival Versus Progression-Free Survival in Oncology Clinical Trials von Aissaoui, A, Bin Sawad, A, Turkistani, F, Aissaoui, N

Volltext

PHP79 - PRICE ANALYSIS OF THERAPEUTIC BIOLOGICS APPROVED BY THE US FOOD AND DRUG ADMINISTRATION (1986–OCTOBER 2015) von Turkistani, F., Alotaibi, A., Alnafesah, A., Seoane-Vazquez, E.

Volltext

AVAILABILITY OF ECONOMIC DATA FOR THERAPEUTIC BIOLOGIC DRUGS IN THE US von Turkistani, F, Seoane-Vazquez, E, Rodriguez-Monguio, R, Bin, Sawad A

Volltext

APPROVALS AND DISCONTINUATIONS OF NEW MOLECULAR ENTITIES AND THERAPEUTIC BIOLOGIC LICENSE APPLICATIONS IN THE UNITED STATES von Turkistani, F, Seoane-Vazquez, E, Rodriguez-Monguio, R, Bin, Sawad A

Volltext